CXCL12-CXCR4/CXCR7 axis in colorectal cancer: therapeutic target in preclinical and clinical studies

T Khare, M Bissonnette, S Khare - International journal of molecular …, 2021 - mdpi.com
Chemokines are chemotactic cytokines that promote cancer growth, metastasis, and
regulate resistance to chemotherapy. Stromal cell-derived factor 1 (SDF1) also known as …

CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression

X Sun, G Cheng, M Hao, J Zheng, X Zhou… - Cancer and Metastasis …, 2010 - Springer
Chemokines, small pro-inflammatory chemoattractant cytokines that bind to specific G-
protein-coupled seven-span transmembrane receptors, are major regulators of cell …

[HTML][HTML] Mechanisms of radiation-induced normal tissue toxicity and implications for future clinical trials

JH Kim, KA Jenrow, SL Brown - Radiation oncology journal, 2014 - ncbi.nlm.nih.gov
To summarize current knowledge regarding mechanisms of radiation-induced normal tissue
injury and medical countermeasures available to reduce its severity. Advances in radiation …

Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4

MP Rettig, G Ansstas, JF DiPersio - Leukemia, 2012 - nature.com
Successful hematopoietic stem cell transplant requires the infusion of a sufficient number of
hematopoietic stem/progenitor cells (HSPCs) that are capable of homing to the bone marrow …

Global remodeling of the vascular stem cell niche in bone marrow of diabetic patients: implication of the microRNA-155/FOXO3a signaling pathway

G Spinetti, D Cordella, O Fortunato, E Sangalli… - Circulation …, 2013 - Am Heart Assoc
Rationale: The impact of diabetes mellitus on bone marrow (BM) structure is incompletely
understood. Objective: Investigate the effect of type-2 diabetes mellitus (T2DM) on BM …

Biogenesis and regulation of cardiovascular microRNAs

J Bauersachs, T Thum - Circulation research, 2011 - Am Heart Assoc
MicroRNAs (miRNAs) are important regulators of gene expression and fundamentally
impact on cardiovascular function in health and disease. A tight control of miRNA expression …

Preclinical development and qualification of ZFN-mediated CCR5 disruption in human hematopoietic stem/progenitor cells

DL DiGiusto, PM Cannon, MC Holmes, L Li… - … therapy Methods & …, 2016 - cell.com
Gene therapy for HIV-1 infection is a promising alternative to lifelong combination antiviral
drug treatment. Chemokine receptor 5 (CCR5) is the coreceptor required for R5-tropic HIV-1 …

Update on clinical experience with AMD3100, an SDF-1/CXCL12–CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells

I Pusic, JF DiPersio - Current opinion in hematology, 2010 - journals.lww.com
AMD3100 was recently FDA-approved for stem cell mobilization in combination with
granulocyte-colony stimulating factor in patients with non-Hodgkin's lymphoma and multiple …

[HTML][HTML] Sources of hematopoietic stem and progenitor cells and methods to optimize yields for clinical cell therapy

SR Panch, J Szymanski, BN Savani… - Biology of Blood and …, 2017 - Elsevier
Bone marrow (BM) aspirates, mobilized peripheral blood, and umbilical cord blood (UCB)
have developed as graft sources for hematopoietic stem and progenitor cells (HSPCs) for …

Recent advances on the use of the CXCR4 antagonist plerixafor (AMD3100, Mozobil™) and potential of other CXCR4 antagonists as stem cell mobilizers

E De Clercq - Pharmacology & therapeutics, 2010 - Elsevier
AMD3100 was originally discovered as an anti-HIV agent effective in inhibiting the
replication of HIV in vitro at nanomolar concentrations. We found it to be a potent and …